Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Origo Acquisition Corp | s102973_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Origo Acquisition Corp | s102973_ex31-2.htm |
| 10-Q - FORM 10-Q - Origo Acquisition Corp | s102973_10q.htm |
Exhibit 32.1
CB PHARMA ACQUISITIONS CORP.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of CB Pharma Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended February 29, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company, as of, and for, the periods presented in the Report.
April 14, 2016
| By: | /s/ Lindsay A. Rosenwald | |
| Lindsay A. Rosenwald, M.D. | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| By: | /s/ George C. Avgerinos | |
| George C. Avgerinos | ||
| Chief Operating Officer | ||
| (Principal Financial and Accounting Officer) | ||